TNFSF10 and pachyonychia congenita: To evaluate the efficacy of our previously developed TRAIL therapy for killing CTCs in blood samples from PC patients, we treated primary patient blood with TRAIL- and E-selectin-coated liposomes as described previously (20, 22, 23) (Fig. 4A).